Rhematoid Arthritis
9
1
2
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 15/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
22%
2 trials in Phase 3/4
100%
1 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (9)
A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis
Persona SoluTion PPS Femur PMCF
Kinesiophobia in Rheumatoid Arthritis: Associations With Functional Disability, Disease Activity, and Related Clinical Factors
Evaluation of CCR6 Gene Expression and Circulating CCL20 Levels as Potential Biomarkers in Rheumatoid Arthritis
Pharmacogenetics of Leflunomide in the Management of Rheumatoid Arthritis
Rehabilitation Approaches Used in Total Knee Replacement
Very Low Dose Prednisolone on Newly Diagnosed Rheumatoid Arthritis
LA Function and Dimensions As Predictors of Disease Activity in RA
An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate